RESUMO
Invasiveness of examination and therapy methods is a serious problem for intensive care and nursing of premature infants. Exhaled breath condensate (EBC) is the most attractive biofluid for non-invasive methods development in neonatology for monitoring the status of intubated infants. The aim of the study was to propose an approach for EBC sampling and analysis from mechanically ventilated neonates. EBC collection system with good reproducibility of sampling was demonstrated. Discovery-based proteomic and metabolomic studies were performed using nano-HPLC coupled to high resolution MS. Label-free semi-quantitative data were compared for intubated neonates with congenital pneumonia (12 infants) and left-sided congenital diaphragmatic hernia (12 infants) in order to define disease-specific features. Totally 119 proteins and 164 metabolites were found. A number of proteins and metabolites that can act as potential biomarkers of respiratory diseases were proposed and require further validation.
Assuntos
Testes Respiratórios/instrumentação , Cromatografia Líquida de Alta Pressão/instrumentação , Hérnias Diafragmáticas Congênitas/diagnóstico , Espectrometria de Massas/instrumentação , Pneumonia/diagnóstico , Biomarcadores/análise , Desenho de Equipamento , Feminino , Hérnias Diafragmáticas Congênitas/metabolismo , Humanos , Recém-Nascido , Masculino , Metaboloma , Metabolômica/instrumentação , Pneumonia/metabolismo , Proteínas/análise , Proteômica/instrumentação , Reprodutibilidade dos TestesRESUMO
Here, the possibility of proteomic and metabolomic analysis of the composition of exhaled breath condensate of neonates with respiratory support. The developed method allows non-invasive collecting sufficient amount of the material for identification of disease-specific biomarkers. Samples were collected by using a condensing device that was incorporated into the ventilation system. The collected condensate was analyzed by liquid chromatography coupled with high resolution mass spectrometry and tandem mass spectrometry. The isolated substances were identified with a use of databases for proteins and metabolites. As a result, a number of compounds that compose the exhaled breath condensate was determined and can be considered as possible biomarkers of newborn diseases or stage of development.